Overview:
Despite increasing awareness and new therapeutic options, malignant pleural mesothelioma (MPM) remains difficult to diagnose and manage. Nonspecific symptoms, imaging overlap, and variable biopsy yield contribute to delayed identification, while evolving immunotherapy-based strategies require thoughtful patient selection and coordinated multidisciplinary care.
This live webcast “D” Is for Diagnosis: Decoding a
Difficult Thoracic Malignancy – Piecing Together a Rare Diagnosis, Preparing
for Tomorrow’s Treatments will immerse learners in an interactive case
that simulates real diagnostic challenges, followed by expert discussion
translating findings into practical management. Faculty will highlight how to
streamline diagnostic workflows, apply current first-line IO-IO and
IO-chemotherapy options, and anticipate emerging approaches including bispecifics.
The program equips clinicians with concise, actionable strategies to improve
timely diagnosis and evidence-based treatment of MPM.
Learning Objectives:
Upon completion of this activity, participants will be able to:
- Apply a structured algorithm for patient evaluation, including selection of appropriate IHC/ancillary tests, to accurately diagnose malignant pleural mesothelioma (MPM)
- Evaluate new evidence supporting frontline options and emerging therapies for MPM
- Integrate the latest data into personalized treatment plans based on patient characteristics
- Describe roles of the multidisciplinary care team in the collaborative management of MPM